Stability Study of Isoniazid and Rifampicin Oral Solutions Using Hydroxypropyl-Β-Cyclodextrin to Treat Tuberculosis in Paediatrics
(1) Background: First-line antituberculosis treatment in paediatrics entails the administration of Isoniazid, Pyrazinamide, and Rifampicin. This study examines the possibility of developing a combined dose liquid formulation for oral use that would facilitate dose adjustment and adherence to treatme...
Saved in:
Main Authors: | Ana Santoveña-Estévez (Author), Javier Suárez-González (Author), Amor R. Cáceres-Pérez (Author), Zuleima Ruiz-Noda (Author), Sara Machado-Rodríguez (Author), Magdalena Echezarreta (Author), Mabel Soriano (Author), José B. Fariña (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use
by: Antonio Lopalco, et al.
Published: (2022) -
Do Ophthalmic Solutions of Amphotericin B Solubilised in 2-Hydroxypropyl-γ-Cyclodextrins Possess an Extended Physicochemical Stability?
by: Philip Chennell, et al.
Published: (2020) -
Improved Stability of Rifampicin in the Presence of Gastric-Resistant Isoniazid Microspheres in Acidic Media
by: Chiluba Mwila, et al.
Published: (2020) -
Preparation and Embedding Characterization of Hydroxypropyl-β-cyclodextrin/Menthyl Acetate Microcapsules with Enhanced Stability
by: Xiaoqing Huang, et al.
Published: (2023) -
Protects Liver From Isoniazid and Rifampicin Drug Toxicity
by: Santosh Kumar Jatav MSc, et al.
Published: (2014)